Furthermore, researchers have examined how DNMTs and TETs may contribute to disease progression and established roles for increased DNMTs in mouse models of prostate cancer [138,139,140] and that TET1 for example is disrupted by copy number changes correlating with reduced 5hMC levels in prostate cancer samples [141]. Here, TET1 is linked to prostate cancer.